‘other losers would just prefer to make flippant remarks as usual’ ~
@bidHow can someone like you
@bid be so wrong, so often but yet still attack posters that have a different opinion?
‘It has only strengthened my personal opinion that DEP-Docetaxel will be a
dud. They should fess up to shareholders, suspend further recruitment, bank the data, save money and move on to the more promising internal drug development.’ ~
@sarge17 July
2022Starpharma finally announce the extraordinarily long-
overdue DEP-Docetaxel Ph2 results in Dec
2023’Fantastic announcement and should silence those who thought DEP doc was a dead duck. To the believers well done. To the doubters I don’t want to say I told you so but I told you so’ ~
@bid Dec
2023May
2024 - Starpharma puts DEP-Docetaxel ‘in the bin’
Flippant remarks indeed.
